Extendicare (TSE:EXE – Get Free Report) had its price objective raised by National Bank Financial from C$32.00 to C$34.00 in a research report issued to clients and investors on Tuesday,BayStreet.CA reports. The brokerage presently has an “outperform” rating on the stock. National Bank Financial’s target price points to a potential upside of 6.35% from the company’s current price.
A number of other equities analysts have also recently weighed in on EXE. Canadian Imperial Bank of Commerce upped their price objective on shares of Extendicare from C$22.00 to C$32.00 in a research report on Thursday, April 2nd. BMO Capital Markets upped their price objective on shares of Extendicare from C$24.00 to C$30.00 in a research report on Monday, March 2nd. Desjardins set a C$34.50 price objective on shares of Extendicare and gave the company a “buy” rating in a research report on Wednesday, April 22nd. TD Securities raised shares of Extendicare from a “hold” rating to a “buy” rating and upped their price objective for the company from C$19.00 to C$32.00 in a research report on Monday, April 6th. Finally, TD increased their price target on shares of Extendicare from C$32.00 to C$39.00 and gave the stock a “buy” rating in a research report on Monday. One research analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the stock. According to data from MarketBeat.com, Extendicare presently has a consensus rating of “Buy” and an average price target of C$31.00.
Extendicare Stock Up 0.5%
Extendicare (TSE:EXE – Get Free Report) last released its quarterly earnings results on Thursday, May 7th. The company reported C$0.42 earnings per share (EPS) for the quarter. Extendicare had a net margin of 6.99% and a return on equity of 45.35%. The firm had revenue of C$465.22 million for the quarter. On average, analysts predict that Extendicare will post 0.6134729 earnings per share for the current year.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Stories
- Five stocks we like better than Extendicare
- AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?
- Axon Surged After Earnings and Is Still Down Over 50% From Highs
- The Event That Could Redefine Appleās Summer Rally
- Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
